Korean Circ J.  2024 Apr;54(4):201-202. 10.4070/kcj.2024.0082.

Requirements of a Usable Scoring System for Risk Stratification in Patients With Coronary Artery Disease

• Kim SS
• Kim HK

• KMID: 2555532
• DOI: http://doi.org/10.4070/kcj.2024.0082

Reference

1. Fuster V. The proliferation of scoring systems: trying to keep our heads out of the clouds. J Am Coll Cardiol. 2017; 69:1640–1641. PMID: 28335846.

2. Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score). Am J Cardiol. 2011; 107:965–971.e1. PMID: 21256468.

3. Lee SH, Kim HK, Jeong MH, et al. Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother. 2021; 7:112–124. PMID: 31977008.

4. Song PS, Kim J, An SY, et al. The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention. Korean Circ J. 2024; 54:189–200.

5. Steensig K, Olesen KK, Madsen M, et al. A novel model for prediction of thromboembolic and cardiovascular events in patients without atrial fibrillation. Am J Cardiol. 2020; 131:40–48. PMID: 32718550.

6. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009; 360:2165–2175. PMID: 19458363.

7. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44:3720–3826. PMID: 37622654.

8. Lee YJ, Suh Y, Kim JS, et al. Ticagrelor monotherapy after 3-month dual antiplatelet therapy in acute coronary syndrome by high bleeding risk: the subanalysis from the TICO trial. Korean Circ J. 2022; 52:324–337. PMID: 35129317.

9. Park MW. Balancing between ischemic and bleeding risk in PCI patients with ‘bi-risk’. Korean Circ J. 2022; 52:338–340. PMID: 35388999.